Definiens, a provider of image and data analysis solutions for quantitative digital pathology, has launched new software that improves productivity in tissue-based research and biomarker development.
The new software widens the functionality of Definiens' current product portfolio and offers a high quality control advantage, with up to a two-fold reduction in hands on time for researchers.
The software removes several bottlenecks in the research process and features end-to-end workflow support from initial image analysis to final results.
The efficient whole-slide review along with the smooth integration of image analysis and data mining capabilities reduces hands-on time, increases productivity and accelerates the development of tissue-based biomarkers.
Definiens Product Marketing Life Sciences director Kai Hartmann said, "The latest release of Definiens' product suite represents the first end-to-end software solution for tissue-based research."